2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases Jun 13 Written by Adam Parks Read the Press Release + Adam Parks https://apollocreativeco.com Previous Previous 2012.08.07. Innovimmune featured in Xconomy
2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases Jun 13 Written by Adam Parks Read the Press Release + Adam Parks https://apollocreativeco.com
